# Tiopronin by BioComp Pharma, Inc.: new human prescription drug listing

**Launch Signal Score:** 65/100

| Field | Value |
|---|---|
| Product | Tiopronin |
| Generic name | Tiopronin |
| NDC | 44523-053 |
| Labeler | BioComp Pharma, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Approval pathway | NDA AUTHORIZED GENERIC |
| Application number | NDA019569 |
| Dosage form | TABLET, SUGAR COATED |
| Route | ORAL |
| Active ingredients | TIOPRONIN 100 mg/1 |
| Pharmacologic class | Reducing and Complexing Thiol [EPC] |
| Marketing start | 2026-09-01 |
| Package configurations | 1 |

## Why this score
- Prescription or biologic product.
- New generic entry: wholesalers and GPOs re-bid contracts.
- Class: Reducing and Complexing Thiol [EPC].

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=44523-053). Last refreshed: 2026-11-03T18:09:00.764Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.